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Ubiquitin-mediated protein modification via covalent attachment of ubiquitin
has emerged as one of the most common regulatory processes in all eukaryotes.
Nedd4-2, closely related to neuronal precursor cell-expressed developmentally
down-regulated 4 (Nedd4), is a multimodular ubiquitin–protein ligase
comprised of four WW domains and a Hect domain. The WW domains
recognize the proline-rich motifs on the multi-subunit amiloride-sensitive
epithelial sodium channel (ENaC). To gain insights into the binding of the WW
domain to proline-rich peptides, a protein fragment (78 amino acids) containing
the fourth WW domain (WW4) of the Nedd4-2 protein was purified and
crystallized and X-ray diffraction data were collected. A data set was obtained
to 2.5 A˚ resolution from a cryocooled single crystal at a synchrotron source. The
crystals belong to the tetragonal space group P41212 (or P43212), with unit-cell
parameters a = b = 113.43, c = 103.21 A˚. Analysis of the self-rotation function
suggests the presence of four WW4 molecules in the asymmetric unit, with a
high unit-cell solvent content of 74%.
1. Introduction
Ubiquitin–protein ligases play an important role in signalling path-
ways and disease processes ranging from developmental abnormal-
ities and autoimmunity to neurodegenerative diseases and cancer
(Hershko & Ciechanover, 1998; Weissman, 2001). Ubiquitylation is a
multistep process involving the successive action of three types of
enzymes: E1, E2 and E3. Ubiquitin–protein ligase (E3) catalyzes the
transfer of ubiquitin from the E2 enzyme to the "-amino group of a
lysine residue on the substrate. E3, either alone or in combination
with its bound E2, determines the exquisite sensitivity of substrate
recognition (Hershko & Ciechanover, 1998). The RING and Hect
types of E3 constitute the two major families of ubiquitin–protein
ligases (Weissman, 2001). The amino-terminal sequences of Hect E3s
are not conserved and contain the primary determinants for specific
substrate recognition. Neuronal precursor cell-expressed develop-
mentally down-regulated 4 protein (Nedd4) is a ubiquitin–protein
ligase (E3) and is a prototypic molecule of an emerging family of
Nedd4-related proteins (Kumar et al., 1997; Harvey & Kumar, 1999).
The Nedd4 family of proteins is involved in diverse cellular func-
tions, such as regulation of membrane channels and permeases, the
cell cycle and transcription (Harvey & Kumar, 1999; Ingham et al.,
2004). Nedd4 was originally identified as a developmentally regulated
mouse gene highly expressed in the early embryonic central nervous
system (Kumar et al., 1992). Human Nedd4 has a modular structure
consisting of an amino-terminal Ca2+/lipid-binding domain followed
by four WW domains (WW1–WW4) and a carboxy-terminal
ubiquitin–protein ligase domain (Hect E3) (Harvey & Kumar, 1999;
Ingham et al., 2004). Nedd4 is known to target the epithelial sodium
channel (ENaC) and voltage-gated sodium channels (Navs) for
degradation (Thomas & Itani, 2004; Fotia et al., 2004). ENaC plays a
major role in regulating blood pressure, and mutations in ENaC that
disrupt the interaction with Nedd4 cause a human hypertensive
disorder, Liddle’s syndrome (Thomas & Itani, 2004). Recent studies
of Nedd4-2 protein, which is closely related to Nedd4, suggest that
Nedd4-2 is the physiological regulator of ENaC and Navs (Harvey et
al., 2001; Kamynina et al., 2001; Fotia et al., 2003, 2004). Unlike
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Nedd4, all Nedd4-2 proteins from various species including human
contain four WW domains followed by a Hect domain (Harvey et al.,
2001; Kamynina et al., 2001). The interaction of WW domains with
the PY motifs of ENaC subunits is proposed to mediate ENaC
ubiquitination by the Hect domain of Nedd4 proteins.
WW domains derive their name from the presence of two highly
conserved tryptophan residues in a sequence of 40 amino acids.
These domains are protein–protein interaction motifs that bind to
proline-rich sequences called PY motifs (Sudol & Hunter, 2000), of
which the PPXY motif is the most common. Binding studies between
the WW domains of Nedd4-2 protein and ENaC subunits containing
PY motifs indicate the requirement of WW3 and WW4 for both
binding to ENaC subunits and regulation of Na+ feedback control of
ENaC in vivo (Fotia et al., 2003). Domains WW1 and WW2 of
Nedd4-2 do not show appreciable affinity for ENaC subunits. An
understanding of the precise atomic interactions between the WW
domains and the target PY motifs is essential to enhance our
knowledge of the principles of molecular recognition of proline-rich
peptides. Towards this goal, we have initiated structural studies of the
WW domain with and without bound peptides. Here, we describe
purification, crystallization and X-ray data collection for the WW4
domain of Nedd4-2 protein. The protein fragment used in the present
study contains 78 amino-acid residues with a molecular weight of
approximately 8.6 kDa. This is the first reported crystallographic
work for an isolated WW domain.
2. Methods and results
2.1. Preparation of WW4 domain of Nedd4-2
AWW4 domain-glutathione S-transferase (GST) construct (Fotia
et al., 2003) was generated by PCR amplification of WW4 domain
from mouse Nedd4-2 cDNA followed by cloning into the EcoRI site
of pGEX-2TK (Amersham Biosciences). This cloned plasmid was
transformed into Escherichia coli strain BL21. Overnight cultures of
E. coli harbouring the GST-WW4 expression plasmid were diluted
1:50, grown for 2 h at 310 K, induced with 1 mM isopropyl -d-
thiogalactoside and grown for an additional 4 h. Bacterial cell pellets
were resuspended in PBS buffer (140 mM NaCl, 2.7 mM KCl, 10 mM
Na2HPO4, 1.8 mM KH2PO4 pH 7.3) with 1 mM DTT and 1 mM
PMSF, sonicated and centrifuged at 10 000g for 20 min. Glutathione-
Sepharose (Amersham Biosciences) was incubated with the cleared
lysate for 1 h at room temperature and the beads were then washed
three times with PBS buffer. The fusion protein was eluted with
glutathione buffer as described previously (Jolliffe et al., 2000). The
GST-WW4 fusion protein was cleaved by incubation with bovine
thrombin according to the manufacturer’s protocol to obtain the
WW4 domain. The WW4 domain was then purified to homogeneity
by gel-filtration chromatography on a HiLoad 16/60 Superdex 30
column (Amersham Biosciences) in PBS buffer with 1 mMDTT. This
WW4 sample eluted as a single peak when analyzed by reverse-phase
HPLC (C18) and migrated as a single band on SDS–PAGE. The
protein was concentrated to 8 mM using Amicon stirred cells with
Millipore ultrafiltration membrane (MWCO of 3 kDa) and stored in
the same PBS buffer.
2.2. Crystallization of WW4 domain
Initial crystallization trials were performed with commercially
available Hampton solutions. Screening was carried out in 24-well
trays using hanging drops containing 2 ml protein solution plus 2 ml
reservoir solution set up for vapour diffusion against 500 ml reservoir
solution at 277 and 293 K. Subsequently, custom-designed crystal-
lization experiments were performed. Crystals of WW4 domain were
obtained at room temperature in about two weeks. The crystallization
droplet contained 8 mM protein, 50 mM sodium citrate pH 6.0, 1 mM
EDTA, 1 mMDTTand 15%(w/v) PEG 10K. The reservoir contained
30%(w/v) PEG 10K and 100 mM sodium citrate buffer pH 6.0. The
reproducibility of crystals was low and most crystallization trials
resulted in overlapped crystals. Only a few crystallization experi-
ments yielded small, isolated and fragile crystals. Repeated seeding
trials resulted in larger crystals suitable for X-ray diffraction
experiments. Prior to data collection, crystals were dipped in reser-
voir solution with 20% glycerol as cryoprotectant and flash-cooled in
liquid nitrogen. Although of good appearance and large size, these
crystals diffracted poorly to approximately 3.5 A˚ resolution at a
synchrotron facility. Consequently, further work including crystal-
lization trials with various additives and flash-cooling crystals using
different cryoprotectants such as MPD, PEG 400 and d-glucose was
undertaken with the aim of obtaining better diffraction. However,
none of these trials improved the diffraction resolution. Several large
crystals obtained by seeding were screened for diffraction, of which
one crystal measuring 0.2  0.2  0.5 mm (Fig. 1) diffracted to 2.5 A˚
resolution.
2.3. X-ray diffraction
A crystal cooled using glycerol as a cryoprotectant was used to
collect X-ray data at a synchrotron source using an ADSCQuantum 4
detector. The data were processed with DENZO and scaled using
SCALEPACK (Otwinowski & Minor, 1997). The crystals belong to a
crystallization communications
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Figure 1
Photograph of a crystal of the WW4 domain of Nedd4-2 protein. A single crystal
with dimensions 0.2  0.2  0.5 mm was used for data collection to 2.5 A˚
resolution.
Table 1
Summary of X-ray diffraction data for the WW4 domain of Nedd4-2 protein.
Values in parentheses are for the last resolution shell.
Temperature (K) 100
X-ray source Synchrotron/CHESS F1
Wavelength (A˚) 0.9124
Resolution range (A˚) 20–2.5 (2.59–2.5)
Space group P41212 (or P43212)
Unit-cell volume (A˚3) 1.33  106
No. of measured reflections 250845
No. of unique reflections 23340
Completeness of data (%) 97.2 (72.1)
Mosaicity () 0.43










tetragonal space group with unit-cell parameters a = b = 113.43,
c = 103.21 A˚. The volume of the unit cell is huge (Table 1) for the size
of the molecular fragment (8.6 kDa), indicating a large number of
molecules and/or a high solvent content. There is no evidence of
oligomerization of this fragment in solution. In order to estimate the
number of molecules in the asymmetric unit, we tried to measure the
experimental density of the crystals using organic solvents such as
ethanol and acetone, but the crystals degraded in the mixture of
solvents. Analysis of the self-rotation function (Tong & Rossmann,
1997) using 10–3.5 A˚ resolution data and a radius of integration of
20 A˚ suggests the presence of four molecules in the asymmetric unit
(Fig. 2) with a solvent content of 74% and a VM of 4.8 A˚
3 Da1, a
value well above the normal range observed for most proteins
(Matthews, 1968). Some examples exhibiting very high solvent
content include colicin Ia (78%; Wiener et al., 1997) and archaeal
virus resolvase SIRV2 (77%; Ennifar et al., 2005). Although it is not
always correct to correlate high solvent content with poor diffraction,
in the present case we presume that the generally poor diffraction
quality (<4.0 A˚ resolution) of even large crystals (0.2  0.2 
0.5 mm) may in part be a consequence of the very high solvent
content. Further optimization of cryoprotection, dehydration and
crystallization protocols may help in improving the diffraction
properties of these crystals.
Structure determination using molecular replacement based on a
model corresponding to the WW segment from the crystal structure
of Pin1–phosphopeptide complex (PDB code 1f8a; Verdecia et al.,
2000) is under way. However, because the model for molecular
replacement accounts for less than 50% of the size of the protein
fragment containing the WW4 domain used here, the chances of a
successful rotation and translation searches are slim. Therefore, we
are also performing trials to obtain heavy-atom derivatives by
treatment of crystals with sodium bromide solution as well as tradi-
tional heavy-atom soaking to determine experimental phases. Addi-
tionally, we are preparing selenomethionine-derivatized protein for
MAD phasing. Furthermore, cocrystallization and soaking experi-
ments to obtain crystals of a WW4–peptide complex are in progress.
The WW4 domain of Nedd4-2 protein binds to -, - and -ENaC
subunits with dissociation constants ranging from 0.77 to 2.1 mM. The
PPXY motifs present in the -ENaC (LALTAPPPAYATLGPS),
-ENaC (PIPGTPPPNYDSLRLQ) and -ENaC (PVPGTPPP-
RYNTLRLD) subunits have been used in binding studies (Fotia et al.,
2003). In our crystallization trials, we have used these 16-mer
peptides and their truncated versions, a rationale normally adopted in
the preparation of protein–peptide complexes (Waksman et al., 1993).
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Figure 2
Self-rotation function with  = 180. The rotation represented by a set of polar
angles (’,  and ) was calculated with GLRF (Tong & Rossmann, 1997) using
diffraction data between 10 and 3.5 A˚ resolution. Contour lines are drawn starting
at 4 r.m.s. (root-mean-square) deviations above the mean in intervals of 1 r.m.s.
deviation. Crystallographic peaks (between 6 and 11 r.m.s deviations) are marked
with a star (*) and non-crystallographic peaks (5 r.m.s. deviations) with a plus sign
(+).
